Cornerstone Robotics Ltd. raised an oversubscribed $200 million series D round to accelerate commercialization of its ...

In a deal worth up to $840 million, Third Arc Bio Inc. is licensing Adagene Inc.’s Safebody technology platform to generate ...

Merck & Co. Inc. is buying Cidara Therapeutics Inc. for $9.2 billion to acquire a late-stage flu candidate and also to ...

A251, a novel HER2 antibody-drug conjugate (ADC) designed to deliver a potent PI3K/PIKK inhibitor directly to tumor cells.

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple ...

A team of five members of the U.S. FDA staff published a review of the use of AI in health care and concluded that while ...

Withings SA received U.S. FDA clearance for Beamo, its health check-up tool designed to monitor heart and lung function. Described as the ‘thermometer of the future’, Beamo combines the sensors of an ...

Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash ...

The U.K. government has published a road map for phasing out animal testing in life sciences research and announced £75 ...

The industry has been complaining about the drug pricing and reimbursement policies of European governments for years, but ...

The U.S. Environmental Protection Agency has moved to relax reporting requirements for perfluoroalkyl and polyfluoroalkyl substances used in a variety of applications, including medical devices.

At first glance, the results of the CLOSURE-AF study would seem to spell doom for left atrial appendage closure devices for ...